Sky Labs, a healthcare startup, said it is launching CART-I, the world’s first ring-type wearable heart rhythm monitoring medical device.
The device measures the irregular pulse of atrial fibrillation (AF) patients using optical sensors, and can automatically measure signals continuously just by wearing it on the finger.
“Clinical studies have shown that CART-I can detect AF with 99 percent accuracy, while electrocardiogram (ECG) measurements can be tracked by touching the ring whenever patients want,” the company said. “The device is also very light as it weighs around 3.75g to the maximum of 4.79g.”
Besides, it has strong proof performance with its IP58 dustproof and waterproof grade and can be worn daily life without any problems. Users can fully recharge the device within two hours, the company added.
Sky Labs has set a price tag of about 400,000 won ($336) for the product.
User data measured by CART-I can also be easily checked in real-time through the company’s Cart-App. Sky Labs explained that the data accumulated on cloud servers could be tracked and analyzed within the desired period making it very effective for early diagnosis based on long-term data analysis.
“As Korean law allows doctors to recommend patients to visit hospitals based on data measured through wearable devices, collaborative inquiries are pouring in from large hospitals,” the company said.
Sky Labs CEO Lee Byung-hwan said, “While there have been various types of wearable ECG devices released, CART-Ⅰ is the first in the world to be able to make continuous measurements for a long time.”
Lee added that the company increased the convenience of collecting data by minimizing the inconvenience of wearing it.
Sky Labs obtained CART-I medical device authorization from the Ministry of Food and Drug Safety in May and aims to obtain European CE certification in August.
As CART-I can add new disease monitoring functions by software updates, the company plans to expand its functions to other diseases such as heart failure, high blood pressure, and respiratory diseases, including Covid-19, the company said.